Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1974 Apr;5(4):413–419. doi: 10.1128/aac.5.4.413

Enhanced Toxicity for Mice of 6-Mercaptopurine with Bacterial Endotoxin

Nelda M Marecki 1, S G Bradley 1
PMCID: PMC428985  PMID: 15825398

Abstract

The toxicity of 6-mercaptopurine was potentiated by 2 mg of either Escherichia coli 026:B6 B endotoxin or Salmonella typhosa 0901 W endotoxin per kg. Nonlethal doses of heat-killed, gram-negative bacteria were also capable of potentiating the lethality of 6-mercaptopurine (6-MP). Salmonella minnesota S, the wild-type strain, and S. minnesota Re 595, a mutant containing only the lipid A and 2-keto-3-deoxyoctonate moiety of the endotoxin molecule, exhibited the same capability to enhance the toxic action of 6-MP. Endotoxin (lipopolysaccharide [LPS]) did not affect the clearance of 6-MP from the circulation, but did alter its apparent metabolism as indicated by blood levels of a metabolite, 6-thiouric acid. The concentration of blood urea nitrogen (BUN) in mice 18 h after injection of 100 mg of 6-MP per kg simultaneously with 2 mg of LPS per kg was significantly elevated over normal values. However, these BUN values were significantly less than those resulting from the administration of one mean lethal dose of either agent. The clearance from the circulation of the gram-negative organism E. coli HB, or the gram-positive organism Staphylococcus epidermidis S, was not affected by 6-MP. Endotoxin had no effect on the clearance of S. epidermidis S, but inhibited that of E. coli HB. When 6-MP and LPS were administered simultaneously with either bacterial species, only the clearance of E. coli HB was inhibited. Mice were protected from the lethality associated with combinations of 6-MP and LPS by (i) prior treatment with phenobarbital, (ii) caffeine, (iii) methylprednisolone, and (iv) polymyxin B sulfate. With the exception of caffeine, each regimen protected mice against the lethal effects of 400 mg of 6-MP per kg, and methylprednisolone or polymyxin B protected mice against 8 mg of LPS per kg.

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D., Young L. S., Meyer R. D., Blevins A. H. Infectious complications of neoplastic disease. Med Clin North Am. 1971 May;55(3):729–745. doi: 10.1016/s0025-7125(16)32514-7. [DOI] [PubMed] [Google Scholar]
  2. Bates H. M., Margolin S. Endotoxin-induced inhibition of renal function in the mouse. Proc Soc Exp Biol Med. 1968 Nov;129(2):642–646. doi: 10.3181/00379727-129-33387. [DOI] [PubMed] [Google Scholar]
  3. Bradley S. G., Rose W. C. Enhanced toxicity for mice of pactamycin with bacterial endotoxin. Antimicrob Agents Chemother. 1973 Jun;3(6):686–692. doi: 10.1128/aac.3.6.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corrigan J. J., Jr, Bell B. M. Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia. Infect Immun. 1971 Nov;4(5):563–566. doi: 10.1128/iai.4.5.563-566.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crocker C. L. Rapid determination of urea nitrogen in serum or plasma without deproteinization. Am J Med Technol. 1967 Sep-Oct;33(5):361–365. [PubMed] [Google Scholar]
  6. Galanos C., Rietschel E. T., Lüderitz O., Westphal O., Kim Y. B., Watson D. W. Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem. 1972 Dec 4;31(2):230–233. doi: 10.1111/j.1432-1033.1972.tb02524.x. [DOI] [PubMed] [Google Scholar]
  7. Marecki N. M., Bradley S. G. Enhanced toxicity for mice of combinations of bacterial endotoxin with antitumor drugs. Antimicrob Agents Chemother. 1973 May;3(5):599–606. doi: 10.1128/aac.3.5.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PHILIPS F. S., STERNBERG S. S., HAMILTON S., CLARKE D. A. The toxic effects of 6-mercaptopurine and related compounds. Ann N Y Acad Sci. 1954 Dec 6;60(2):283–296. doi: 10.1111/j.1749-6632.1954.tb40019.x. [DOI] [PubMed] [Google Scholar]
  9. Peavy D. L., Shands J. W., Jr, Adler W. H., Smith R. T. Mitogenicity of bacterial endotoxins: characterization of the mitogenic principle. J Immunol. 1973 Aug;111(2):352–357. [PubMed] [Google Scholar]
  10. Rose W. C., Bradley S. G. Enhanced toxicity for mice of combinations of antibiotics with Escherichia coli cells or Salmonella typhosa endotoxin. Infect Immun. 1971 Nov;4(5):550–555. doi: 10.1128/iai.4.5.550-555.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rose W. C., Bradley S. G., Lee I. P. Potentiation of the toxicity of several antitumor agents by Salmonella typhosa endotoxin. Toxicol Appl Pharmacol. 1972 Sep;23(1):102–111. doi: 10.1016/0041-008x(72)90209-8. [DOI] [PubMed] [Google Scholar]
  12. Seyberth H. W., Schmidt-Gayk H., Hackenthal E. Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate. Toxicon. 1972 Aug;10(5):491–500. doi: 10.1016/0041-0101(72)90175-4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES